Prostate cancer prognosis linked to prostate-specific antigen levels below threshold. After treatment for metastatic prostate cancer, a drop in prostate-specific antigen (PSA) levels in the blood is an indicator that treatment is working.
A apuração publicada por medicalxpress.com vira base para uma leitura editorial direta e contextualizada.
Trechos de apoio da pauta: After treatment for metastatic prostate cancer, a drop in prostate-specific antigen (PSA) levels in the blood is an indicator that treatment is working. A recent real-world study indicates that reaching a PSA level below 0.2 ng/mL is an indicator of improved patient survival.
- Ponto de atenção: prostate.
- Ponto de atenção: cancer.
- Ponto de atenção: prognosis.
Em resumo, a leitura editorial acompanha o impacto do tema no nicho Fitness.
